In recent years, considerable attention has been paid to the spread of bacterial resistance to antibiotics, disinfectants, and antiseptics. There are few effective antimicrobial drugs left, the creation of new ones requires significant costs. The WHO defines bacteriophages as a «new therapeutic approach» as an alternative in the fight against bacterial pathogens. Undoubtedly, healthcare organizers, epidemiologists and clinicians currently need an up-to-date assessment of the evidence regarding the benefits, efficacy and safety of bacteriophage therapy, as well as the use of phages for the control and prevention of infections (for example, in a complex of anti-epidemic measures, biological disinfection).

1. Aslanov B. I. Epidemiologicheskaya ocenka bakteriofagov kak faktorov evolyucii gospital’nyh shtammov i sredstv bor’by s vnutribol’nichnymi infekciyami / Avtoref. diss. na soiskanie uch. stepeni kand.med.nauk. – Sankt- Peterburg. – 2016. – 44 s.

2. Abedon, S. T. Phage Therapy: Various perspectives on how to improve the art / Methods Mol Biol. –2018. – 1734. – R. 113–127. doi: 10.1007/978-1-4939-7604-1_11.

3. El Haddad L., Harb C., GebaraM., Stibich M. et al. Evaluation of bacteriophage therapy against the multidrug resistant ESKAPE organisms in an immunocompromised model: a systematic review / PROSPERO 2018 CRD42018088332. (http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD4201808833

4. David S. et al. Bacteriofagen: huidige kennis, onderzoek en toepassingen // RIVM Briefrapport 2018-0044. 38 p.Available from http://hdl.handle.net/10029/621984

5. Zaripova T. N., Muhina V. I, CHujkova K. I. Obosnovanie ispol’zovaniya bakteriofaga v lechenii bol’nyh s obostreniem hronicheskogo laringita – lic golosorechevyh professij / Otorinolaringologiya. 2013. – Tom 14. – S. 1008–1014.

6. Jault P., Leclerc T., Jennes S., Pirnay J. P. et al Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase ½ trial /. // LancetInfect Dis. – 2019. – № 19 (1). – R. 35–45.

7. Lavreneva G. V., Nesterova K. I. Obosnovanie konservativnogo lecheniya hronicheskogo tonzillita u lic starshih vozrastnyh grupp metodami «myagkoj» terapii / G. V. Lavreneva, K. I. Nesterova, K. V. YAremenko, A. A. Nesterova // Vestn. otorinolar. – 2016. – № 4. – S. 22–26.

8. Merkov A. M., Polyakov L. E. Sanitarnaya statistika, L., 1974; Rukovodstvo po social’noj gigiene i organizacii zdravoohraneniya, 3 izd., t. 1, M. 1974.

9. Medina C, López-Baena FJ, editor(s). Host-pathogen interactions: methods and protocols, Methods in molecular biology. 2018; 1734. https://doi.org/10.1007/978-1-4939-7604-1_11

10. Moeling K., Broecker F., Will C A wake-up call: we need phage therapy now // Viruses. – 2018. – № 10. – R. 688. doi: 10.3390/v10120688

11. Morozova V. V., Vlassov V. V., Tikunova N. V. Applications of bacteriophages in the treatment of localized infections in humans / // Front Microbiol. – 2018. – 9. – R. 1696. https://doi.org/10.3389/fmicb.2018.01696

12. Parfenyuk R. L. Mikrobiologicheskie osnovy peroral’noj fagoterapii gnojno-vospalitel’nyh zabolevanij / Avtoref. dis. kand. med. nauk. – Moskva., 2004. – 35 s.

13. Raya R. R., Hébert E. M. Isolation of phage via induction of lysogens. Bacteriophages: Methods and Protocols, Volume 1: Isolation, Characterization, and Interaction / M. Clokie, A. Kropinski, eds. 2009; 501: 23–32.

14. Rohde C., Wittman J., Kutter E. Bacteriophages: a therapy concept against multi-drug resistant bacteria / // Surgical infections. – 2018. – № 19 (8). – R. 1–8. doi.org/10.1089/sur.2018.184

15. Racional’noe primenenie bakteriofagov v lechebnoj i protivoepidemi-cheskoj praktike. Federal’nye klinicheskie rekomendacii / B. I. Aslanov, L. P. Zueva, L. A. Kaftyreva, A. G. Bojcov, V. G. Akimkin, A. A. Dolgij, E. B. Brusina, O. M. Drozdova. – M., 2014. – 54 s.

16. Saperkin N. V., Kovalishena O. V. , Kvashnina D. V ,. Rauzendal E , Skholten R. Effektivnost’ ispol’zovaniya bakteriofagov dlya lecheniya i profilak-tiki infekcii: sistematicheskij obzor ZHurnal infektologii. – 2019. – Tom 11. – № 4. – S. 19–30.

17. Chanysheva O. V., KovalishenaT. V., Prisada R. F. Optimizaciya primeneniya bakteriofagov dlya bor’by s infekciyami po rezul’tatam regional’nogo mikrobiologicheskogo monitoringa / Medicinskij al’manah. – 2017. – № 4 (49). – S. 33–37.

18. UP Centr ekspertiz i ispytanij v zdravoohranenii 1998-2021gg. Gosudarstvennyj reestr lekarstvennyh sredstv Respubliki Belarus’ № 1779 s. 18

19. Chernyavskij V. I. Bakterial’nye bioplenki i infekcii / Annals of Mechnikov Institute, N 1. – 2013. – 86 s. www.imiamn.org.ua/journal.htm

20. Novosti IPATH: https://health.ucsd.edu/news/topics/phagetherapy/Pages/Phage-News.aspx* Can bacteria-slaying viruses defeat antibiotic-resistant infections? A new U. S. clinical center aims to find out (By Kelly Servick) // Science, Jun 21, 2018. doi:10.1126/science.aau5414